| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8669606 | The Journal of Heart and Lung Transplantation | 2018 | 16 Pages |
Abstract
Proteinuria, which was present in 25% of all tested LVAD patients, predicts worse outcome in all-cause mortality and need of RRT in patients with a CF-LVAD. This warrants the use of proteinuria in risk stratification when selecting patients for CF-LVAD therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Rahatullah BSc, Kadir MD, PhD, Sakir MD, Kavita MD, Nisha A. MD, Jasper J. MD, PhD, Brian MD, Glenn MD, Ryan J. MD, Dennis A. MD, PhD, Ad J.J.C. MD, PhD, Olivier C. MD, PhD, Stuart D. MD,